Jones, R. J., Bjorklund, C. C., Baladandayuthapani, V., Kuhn, D. J., & Orlowski, R. Z. (2012). Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase is Mediated by Point Mutations of p53, but can be Overcome with the p53 Targeting Agent RITA.
Citación estilo ChicagoJones, Richard J., Chad C. Bjorklund, Veerabhadran Baladandayuthapani, Deborah J. Kuhn, and Robert Z. Orlowski. Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated By Point Mutations of P53, but Can Be Overcome With the P53 Targeting Agent RITA. 2012.
Cita MLAJones, Richard J., et al. Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated By Point Mutations of P53, but Can Be Overcome With the P53 Targeting Agent RITA. 2012.